nodes	percent_of_prediction	percent_of_DWPC	metapath
Dextropropoxyphene—Loperamide—POMC—adrenal gland cancer	0.451	0.456	CrCbGaD
Dextropropoxyphene—Toremifene—ABCB1—adrenal gland cancer	0.0965	0.0977	CrCbGaD
Dextropropoxyphene—Phenylbutazone—PTGS2—adrenal gland cancer	0.0856	0.0866	CrCbGaD
Dextropropoxyphene—Propafenone—ABCB1—adrenal gland cancer	0.068	0.0689	CrCbGaD
Dextropropoxyphene—Bepridil—ABCB1—adrenal gland cancer	0.0606	0.0614	CrCbGaD
Dextropropoxyphene—Fentanyl—ABCB1—adrenal gland cancer	0.0557	0.0564	CrCbGaD
Dextropropoxyphene—Loperamide—ABCB1—adrenal gland cancer	0.0537	0.0544	CrCbGaD
Dextropropoxyphene—Trimipramine—ABCB1—adrenal gland cancer	0.0403	0.0408	CrCbGaD
Dextropropoxyphene—Tamoxifen—ABCB1—adrenal gland cancer	0.0385	0.039	CrCbGaD
Dextropropoxyphene—Methadone—ABCB1—adrenal gland cancer	0.0382	0.0387	CrCbGaD
Dextropropoxyphene—OPRD1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.000731	0.0588	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.000641	0.0515	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide GPCRs—GNRHR—adrenal gland cancer	0.000542	0.0436	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000433	0.0348	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide GPCRs—TSHR—adrenal gland cancer	0.00039	0.0314	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide GPCRs—TSHR—adrenal gland cancer	0.000342	0.0275	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide GPCRs—TSHR—adrenal gland cancer	0.000289	0.0233	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Codeine and Morphine Metabolism—ABCB1—adrenal gland cancer	0.000283	0.0228	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G-protein activation—POMC—adrenal gland cancer	0.000254	0.0204	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000231	0.0185	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000202	0.0163	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Opioid Signalling—PRKACA—adrenal gland cancer	0.000193	0.0155	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000176	0.0141	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRHR—adrenal gland cancer	0.000171	0.0137	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000155	0.0124	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.000154	0.0124	CbGpPWpGaD
Dextropropoxyphene—OPRM1—TCR Signaling Pathway—CDC42—adrenal gland cancer	0.000151	0.0121	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000141	0.0114	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000138	0.0111	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000135	0.0108	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—GNRHR—adrenal gland cancer	0.00013	0.0105	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000123	0.0099	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000121	0.00974	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000115	0.00927	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000108	0.00868	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Opioid Signalling—POMC—adrenal gland cancer	0.000105	0.00848	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000105	0.00846	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000102	0.00823	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—GNRHR—adrenal gland cancer	9.92e-05	0.00798	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—TSHR—adrenal gland cancer	9.37e-05	0.00754	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.34e-05	0.00751	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	9.33e-05	0.0075	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—GNRH1—adrenal gland cancer	9.22e-05	0.00742	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	9.12e-05	0.00734	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—GNRHR—adrenal gland cancer	9.01e-05	0.00725	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—GNAS—adrenal gland cancer	9e-05	0.00724	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	8.89e-05	0.00715	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—GNRHR—adrenal gland cancer	8.7e-05	0.007	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—TSHR—adrenal gland cancer	8.22e-05	0.00661	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—GNRHR—adrenal gland cancer	7.9e-05	0.00635	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—GNAS—adrenal gland cancer	7.9e-05	0.00635	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—GNRH1—adrenal gland cancer	7.79e-05	0.00627	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—GNRHR—adrenal gland cancer	7.35e-05	0.00591	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.21e-05	0.0058	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	7.19e-05	0.00578	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—TSHR—adrenal gland cancer	6.95e-05	0.00559	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—GNRHR—adrenal gland cancer	6.68e-05	0.00537	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—GNAS—adrenal gland cancer	6.67e-05	0.00537	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	6.66e-05	0.00535	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	6.3e-05	0.00507	CbGpPWpGaD
Dextropropoxyphene—OPRD1—G alpha (i) signalling events—POMC—adrenal gland cancer	6.06e-05	0.00488	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—GNRH1—adrenal gland cancer	5.94e-05	0.00478	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.92e-05	0.00476	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.87e-05	0.00472	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.85e-05	0.0047	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—GNAS—adrenal gland cancer	5.45e-05	0.00439	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Arachidonic acid metabolism—PTGS2—adrenal gland cancer	5.42e-05	0.00436	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—GNRH1—adrenal gland cancer	5.4e-05	0.00434	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Peptide ligand-binding receptors—POMC—adrenal gland cancer	5.33e-05	0.00428	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GNRHR—adrenal gland cancer	5.32e-05	0.00428	CbGpPWpGaD
Dextropropoxyphene—OPRK1—G alpha (i) signalling events—POMC—adrenal gland cancer	5.32e-05	0.00428	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—TSHR—adrenal gland cancer	5.3e-05	0.00426	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—GNRH1—adrenal gland cancer	5.21e-05	0.00419	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	4.96e-05	0.00399	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SH3KBP1—adrenal gland cancer	4.95e-05	0.00398	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.82e-05	0.00388	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—TSHR—adrenal gland cancer	4.81e-05	0.00387	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.8e-05	0.00386	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—GNAS—adrenal gland cancer	4.78e-05	0.00385	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.76e-05	0.00383	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—GNRH1—adrenal gland cancer	4.73e-05	0.00381	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GNRHR—adrenal gland cancer	4.67e-05	0.00375	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—ZNRF3—adrenal gland cancer	4.65e-05	0.00374	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—TSHR—adrenal gland cancer	4.64e-05	0.00374	CbGpPWpGaD
Dextropropoxyphene—OPRM1—G alpha (i) signalling events—POMC—adrenal gland cancer	4.49e-05	0.00361	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—SDHB—adrenal gland cancer	4.43e-05	0.00357	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—GNRH1—adrenal gland cancer	4.4e-05	0.00354	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SH3KBP1—adrenal gland cancer	4.34e-05	0.00349	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	4.23e-05	0.0034	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—TSHR—adrenal gland cancer	4.22e-05	0.00339	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—ZNRF3—adrenal gland cancer	4.08e-05	0.00328	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—GNAS—adrenal gland cancer	4.04e-05	0.00325	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—GNRH1—adrenal gland cancer	4e-05	0.00322	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GNRHR—adrenal gland cancer	3.94e-05	0.00317	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—TSHR—adrenal gland cancer	3.93e-05	0.00316	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	3.87e-05	0.00311	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR ligand binding—POMC—adrenal gland cancer	3.67e-05	0.00295	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SH3KBP1—adrenal gland cancer	3.67e-05	0.00295	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	3.57e-05	0.00287	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—TSHR—adrenal gland cancer	3.56e-05	0.00287	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—PRKACA—adrenal gland cancer	3.45e-05	0.00278	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—ZNRF3—adrenal gland cancer	3.45e-05	0.00277	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—CDC42—adrenal gland cancer	3.22e-05	0.00259	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR ligand binding—POMC—adrenal gland cancer	3.22e-05	0.00259	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GNRH1—adrenal gland cancer	3.19e-05	0.00256	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	3.14e-05	0.00252	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Biological oxidations—POMC—adrenal gland cancer	3.11e-05	0.0025	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—GNAS—adrenal gland cancer	3.08e-05	0.00248	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—PRKACA—adrenal gland cancer	3.03e-05	0.00244	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	3e-05	0.00241	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—CDC42—adrenal gland cancer	2.93e-05	0.00236	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—SPRY2—adrenal gland cancer	2.92e-05	0.00235	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—RRM1—adrenal gland cancer	2.86e-05	0.0023	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—SDHD—adrenal gland cancer	2.86e-05	0.0023	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TSHR—adrenal gland cancer	2.84e-05	0.00229	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—CDC42—adrenal gland cancer	2.83e-05	0.00227	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—GNAS—adrenal gland cancer	2.8e-05	0.00225	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GNRH1—adrenal gland cancer	2.8e-05	0.00225	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SDHB—adrenal gland cancer	2.78e-05	0.00223	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR ligand binding—POMC—adrenal gland cancer	2.72e-05	0.00219	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—GNAS—adrenal gland cancer	2.7e-05	0.00217	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—MEN1—adrenal gland cancer	2.67e-05	0.00215	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—CDC42—adrenal gland cancer	2.57e-05	0.00207	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—PRKACA—adrenal gland cancer	2.56e-05	0.00206	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—SPRY2—adrenal gland cancer	2.56e-05	0.00206	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	2.55e-05	0.00205	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Biological oxidations—POMC—adrenal gland cancer	2.53e-05	0.00203	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TSHR—adrenal gland cancer	2.49e-05	0.002	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—GNAS—adrenal gland cancer	2.45e-05	0.00197	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	2.44e-05	0.00196	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—CDC42—adrenal gland cancer	2.39e-05	0.00192	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GNRH1—adrenal gland cancer	2.36e-05	0.0019	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—MEN1—adrenal gland cancer	2.34e-05	0.00188	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—GNAS—adrenal gland cancer	2.28e-05	0.00184	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SDHB—adrenal gland cancer	2.28e-05	0.00183	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SDHB—adrenal gland cancer	2.26e-05	0.00182	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	2.19e-05	0.00176	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—CDC42—adrenal gland cancer	2.17e-05	0.00175	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—SPRY2—adrenal gland cancer	2.16e-05	0.00174	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—MED12—adrenal gland cancer	2.13e-05	0.00171	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TSHR—adrenal gland cancer	2.11e-05	0.00169	CbGpPWpGaD
Dextropropoxyphene—OPRD1—GPCR downstream signaling—POMC—adrenal gland cancer	2.07e-05	0.00167	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—GNAS—adrenal gland cancer	2.07e-05	0.00167	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—PRKACA—adrenal gland cancer	2.04e-05	0.00164	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—MEN1—adrenal gland cancer	1.98e-05	0.00159	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—POMC—adrenal gland cancer	1.88e-05	0.00152	CbGpPWpGaD
Dextropropoxyphene—OPRK1—GPCR downstream signaling—POMC—adrenal gland cancer	1.82e-05	0.00146	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—SDHD—adrenal gland cancer	1.79e-05	0.00144	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—RRM1—adrenal gland cancer	1.79e-05	0.00144	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—PRKACA—adrenal gland cancer	1.79e-05	0.00144	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	1.78e-05	0.00143	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CDC42—adrenal gland cancer	1.73e-05	0.00139	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IGF2—adrenal gland cancer	1.67e-05	0.00134	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	1.67e-05	0.00134	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—GNAS—adrenal gland cancer	1.65e-05	0.00133	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—POMC—adrenal gland cancer	1.65e-05	0.00133	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—IGF1R—adrenal gland cancer	1.61e-05	0.0013	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	1.55e-05	0.00125	CbGpPWpGaD
Dextropropoxyphene—OPRM1—GPCR downstream signaling—POMC—adrenal gland cancer	1.54e-05	0.00124	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CDC42—adrenal gland cancer	1.52e-05	0.00122	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—PRKACA—adrenal gland cancer	1.51e-05	0.00122	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SDHB—adrenal gland cancer	1.49e-05	0.0012	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—RRM1—adrenal gland cancer	1.47e-05	0.00118	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—SDHD—adrenal gland cancer	1.47e-05	0.00118	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF2—adrenal gland cancer	1.46e-05	0.00118	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—RRM1—adrenal gland cancer	1.46e-05	0.00117	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—SDHD—adrenal gland cancer	1.46e-05	0.00117	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—GNAS—adrenal gland cancer	1.45e-05	0.00117	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—IGF1R—adrenal gland cancer	1.41e-05	0.00114	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—POMC—adrenal gland cancer	1.4e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TERT—adrenal gland cancer	1.39e-05	0.00112	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—MED12—adrenal gland cancer	1.33e-05	0.00107	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CDC42—adrenal gland cancer	1.28e-05	0.00103	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—GNAS—adrenal gland cancer	1.26e-05	0.00101	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	1.24e-05	0.000995	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF2—adrenal gland cancer	1.24e-05	0.000994	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—GNAS—adrenal gland cancer	1.22e-05	0.000985	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TERT—adrenal gland cancer	1.22e-05	0.000979	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—BAD—adrenal gland cancer	1.21e-05	0.000971	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—IGF1R—adrenal gland cancer	1.19e-05	0.000961	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	1.19e-05	0.000959	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—POMC—adrenal gland cancer	1.11e-05	0.000895	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—BRAF—adrenal gland cancer	1.1e-05	0.000884	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.1e-05	0.000881	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—MED12—adrenal gland cancer	1.09e-05	0.000874	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling by GPCR—EGFR—adrenal gland cancer	1.07e-05	0.000857	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—BAD—adrenal gland cancer	1.06e-05	0.000852	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TERT—adrenal gland cancer	1.03e-05	0.000827	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—POMC—adrenal gland cancer	9.76e-06	0.000785	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PRKACA—adrenal gland cancer	9.73e-06	0.000783	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	9.71e-06	0.000781	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—BRAF—adrenal gland cancer	9.64e-06	0.000775	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—RRM1—adrenal gland cancer	9.6e-06	0.000773	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—SDHD—adrenal gland cancer	9.6e-06	0.000773	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	9.51e-06	0.000765	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling by GPCR—EGFR—adrenal gland cancer	9.34e-06	0.000751	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BAD—adrenal gland cancer	8.95e-06	0.00072	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—POMC—adrenal gland cancer	8.48e-06	0.000682	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—POMC—adrenal gland cancer	8.25e-06	0.000664	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—BRAF—adrenal gland cancer	8.14e-06	0.000655	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	7.99e-06	0.000643	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—CTNNB1—adrenal gland cancer	7.94e-06	0.000639	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PRKACA—adrenal gland cancer	7.92e-06	0.000637	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling by GPCR—EGFR—adrenal gland cancer	7.89e-06	0.000635	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—GNAS—adrenal gland cancer	7.89e-06	0.000635	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	7.74e-06	0.000623	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—ABCB1—adrenal gland cancer	7.74e-06	0.000623	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—MED12—adrenal gland cancer	7.16e-06	0.000576	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—CTNNB1—adrenal gland cancer	6.96e-06	0.00056	CbGpPWpGaD
Dextropropoxyphene—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	6.77e-06	0.000544	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—GNAS—adrenal gland cancer	6.48e-06	0.000521	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—GNAS—adrenal gland cancer	6.42e-06	0.000516	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	6.35e-06	0.000511	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—ABCB1—adrenal gland cancer	6.3e-06	0.000507	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—EGFR—adrenal gland cancer	6.29e-06	0.000506	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—CTNNB1—adrenal gland cancer	5.89e-06	0.000474	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—EGFR—adrenal gland cancer	5.52e-06	0.000444	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—POMC—adrenal gland cancer	5.31e-06	0.000427	CbGpPWpGaD
Dextropropoxyphene—OPRD1—Signaling Pathways—TP53—adrenal gland cancer	5.28e-06	0.000425	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	5.22e-06	0.00042	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—EGFR—adrenal gland cancer	4.66e-06	0.000375	CbGpPWpGaD
Dextropropoxyphene—OPRK1—Signaling Pathways—TP53—adrenal gland cancer	4.63e-06	0.000373	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—POMC—adrenal gland cancer	4.36e-06	0.000351	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—POMC—adrenal gland cancer	4.32e-06	0.000348	CbGpPWpGaD
Dextropropoxyphene—CYP2C8—Metabolism—PTGS2—adrenal gland cancer	4.24e-06	0.000341	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—GNAS—adrenal gland cancer	4.23e-06	0.000341	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	4.15e-06	0.000334	CbGpPWpGaD
Dextropropoxyphene—OPRM1—Signaling Pathways—TP53—adrenal gland cancer	3.92e-06	0.000315	CbGpPWpGaD
Dextropropoxyphene—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	3.48e-06	0.00028	CbGpPWpGaD
Dextropropoxyphene—CYP2C9—Metabolism—PTGS2—adrenal gland cancer	3.45e-06	0.000277	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—POMC—adrenal gland cancer	2.85e-06	0.000229	CbGpPWpGaD
Dextropropoxyphene—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	2.27e-06	0.000183	CbGpPWpGaD
